We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$86.3B
AUM Growth
-$7.68B
(-8.2%)
Cap. Flow
-$13B
Cap. Flow
% of AUM
-15.06%
Top 10 Holdings %
Top 10 Hldgs %
22.87%
Holding
2,645
New
347
Increased
664
Reduced
827
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$198M |
| 2 |
PayPal
PYPL
|
+$179M |
| 3 |
Vail Resorts
MTN
|
+$177M |
| 4 |
HEICO Corp
HEI
|
+$160M |
| 5 |
S&P Global
SPGI
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$350M |
| 2 |
CDW
CDW
|
+$280M |
| 3 |
Alibaba
BABA
|
+$258M |
| 4 |
Public Storage
PSA
|
+$247M |
| 5 |
Labcorp
LH
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.92% |
| 4 | Industrials | 9.55% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Safe Bulkers
SB
$774M
| $70K | ﹤0.01% |
+14,792
| New | +$60.4K |
|
|
SGMO
1352
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $70K | ﹤0.01% |
12,168
+3,342
| +38% | +$19.9K |
|
1353
Syndax Pharmaceuticals
SNDX
$1.82B
| $70K | ﹤0.01% |
4,040
+26
| +0.6% | +$438 |
|
1354
Agilon Health
AGL
$1.6B
| $69K | ﹤0.01% |
+110
| New | +$56.7K |
|
1355
Avista
AVA
$3.24B
| $69K | ﹤0.01% |
1,540
+986
| +178% | +$43.4K |
|
1356
Casey's General Stores
CASY
$30.9B
| $69K | ﹤0.01% |
349
-119
| -25% | -$22.4K |
|
1357
Celsius Holdings
CELH
$7.03B
| $69K | ﹤0.01% |
+3,804
| New | +$68.3K |
|
1358
Descartes Systems
DSGX
$6.82B
| $69K | ﹤0.01% |
953
-86
| -8% | -$6.2K |
|
1359
Fox Factory Holding Corp
FOXF
$886M
| $69K | ﹤0.01% |
+712
| New | +$87.9K |
|
1360
Organogenesis Holdings
ORGO
$239M
| $69K | ﹤0.01% |
9,106
+8,873
| +3,808% | +$68.7K |
|
1361
RCI Hospitality Holdings
RICK
$215M
| $69K | ﹤0.01% |
1,129
| – | – |
|
1362
Sun Communities
SUI
$14.7B
| $69K | ﹤0.01% |
395
-3,473
| -90% | -$646K |
|
|
VWTR
1363
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $69K | ﹤0.01% |
+4,501
| New | +$54.7K |
|
|
AMED
1364
DELISTED
Amedisys
AMED
| $68K | ﹤0.01% |
+399
| New | +$59.6K |
|
1365
Amphastar Pharmaceuticals
AMPH
$916M
| $68K | ﹤0.01% |
1,917
+71
| +4% | +$2.01K |
|
1366
Beyond Meat
BYND
$277M
| $68K | ﹤0.01% |
1,426
-1,090
| -43% | -$59.9K |
|
1367
Essent Group
ESNT
$6.33B
| $68K | ﹤0.01% |
1,668
+509
| +44% | +$22.6K |
|
1368
Huron Consulting
HURN
$2.42B
| $68K | ﹤0.01% |
+1,501
| New | +$69.2K |
|
|
MAPS
1369
DELISTED
WM TECHNOLOGY INC A
MAPS
| $68K | ﹤0.01% |
+8,751
| New | +$49.7K |
|
1370
MeiraGTx Holdings
MGTX
$1.21B
| $68K | ﹤0.01% |
+4,949
| New | +$76.2K |
|
1371
Concrete Pumping Holdings
BBCP
$491M
| $67K | ﹤0.01% |
10,060
+1,006
| +11% | +$7.72K |
|
1372
Ethan Allen Interiors
ETD
$603M
| $67K | ﹤0.01% |
2,596
| – | – |
|
1373
Kulicke & Soffa
KLIC
$4.78B
| $67K | ﹤0.01% |
1,204
-99
| -8% | -$5.46K |
|
1374
Keros Therapeutics
KROS
$221M
| $67K | ﹤0.01% |
+1,237
| New | +$63.5K |
|
|
REVG
1375
DELISTED
REV Group
REVG
| $67K | ﹤0.01% |
+5,058
| New | +$69K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Lazard Asset Management held 2,645 positions worth $86.3B, down 8.2% from $94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $13B in Q1 2022, closing 297 positions and reducing 827 holdings. Its most notable exit was Stericycle Inc, an estimated $70.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vail Resorts worth $169M.
- Lazard Asset Management's largest Q1 2022 buy was Vail Resorts: 649,949 shares worth $169M.
- Lazard Asset Management added most to Nike in Q1 2022, an estimated $198M increase.
- Lazard Asset Management's biggest Q1 2022 reduction was Medtronic, cutting an estimated $350M.
- Lazard Asset Management fully exited Stericycle Inc in Q1 2022, selling an estimated $70.3M.
- Lazard Asset Management's ten largest holdings make up 23% of its $86.3B portfolio in Q1 2022.
- Lazard Asset Management opened 347 new positions and closed 297 in Q1 2022.
- Lazard Asset Management's portfolio value fell 8.2% quarter-over-quarter to $86.3B.
Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.